Compositions, methods and uses for poxvirus elements in vaccine constructs

US9011874B2 · kind B2 · utility

Assignee

• Takeda Vaccines, Inc. · US

Inventors

• Dan T. Stinchcomb · Boulder, US
• Jorge E. Osorio · Mount Horeb, US
• Timothy D. Powell · Fort Collins, US
• Jeremy C. Jones · Madison, US

Key dates

• Filing date: Nov 22, 2010
• Grant date: Apr 21, 2015
• Expiry date: Nov 22, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2760/16134
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions. In other embodiments, vaccine compositions are reported of use in a subject.